11890040 · Active · incorporated 7 years, 5 months ago · London
Biotech Biotech & Life Sciences Deep Tech Drug Discovery Healthcare Series B+
A clinical-stage biotechnology company developing engineered T-regulatory cell therapies for severe immune-mediated diseases.
Quell Therapeutics is a private limited company registered at Companies House under number 11890040, incorporated on 19 March 2019, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 88 filings for this company, including 2 funding rounds. Its most recent round closed in June 2023, raising £19.9m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 2 | Jun 2023 | £19.9m | £1.65 |
| Round 1 | Mar 2022 | £166.7m | £1.89 |
Showing the 13 most recent of 88 filings.
See the complete cap table with every shareholder, founder tags, dilution across 16 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.